ArticleJournal of medicinal chemistry2026
Keggin-Type Polyoxometalates as a Systematic Antiviral Scaffold: Activity, Cytotoxicity, and Solution Stability across Heteroion and Addenda Metal Variations.
Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polyoxometalates (POMs) are promising antiviral agents, yet systematic structure-activity relationships remain scarce and biological stability is rarely assessed. Here we report the antiviral activity, cytotoxicity, and solution speciation of 11 Keggin-type POMs spanning three compositional series─PVxW12-x, PVxMo12-x, and SiMoxW12-x (x = 0-3)─alongside lacunary derivatives, and simple metal salt controls. Multinuclear NMR spectroscopy (31P, 51V, 183W) in cell culture medium under assay conditions revealed a direct correlation between cluster integrity and antiviral potency: compounds that decompose are uniformly inactive while structurally stable or partially transformed clusters show concentration-dependent inhibition. The silicomolybdotungstate series proved most promising, with [SiW12O40]4- and [SiMoW11O40]4- achieving IC50 values of 26.0 and 24.9 μM against HCoV-OC43. Antiviral potency correlates with overall cluster charge, with 4- anions consistently outperforming their 3- and 6- analogues─an observation rationalized through the superchaotropic ion concept.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.